The impact of interventions to improve the quality of prescribing and use of antibiotics in primary care patients with respiratory tract infections: A systematic review protocol

BMJ Open

Volumn 7, Issue 6, 2017, Pages

  Martínez González, Nahara Anani ^a   Coenen, Samuel ^b   Plate, Andreas ^a   Colliers, Annelies ^b   Rosemann, Thomas ^a   Senn, Oliver ^a   Neuner Jehle, Stefan ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Acute Respiratory Tract Infections; Anti Bacterial Agents Use; Antibiotic Use; Infectious Diseases; Prescriptions; Prudent Antibiotic Use; Quality Of Antibiotic Prescribing; Quality Of Antibiotic Use; Systematic Review

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT;

CLINICAL EFFECTIVENESS; HUMAN; INTERVENTION STUDY; OUTCOME ASSESSMENT; PEER REVIEW; PRESCRIPTION; PRIMARY MEDICAL CARE; PROGRAM ACCEPTABILITY; PROGRAM FEASIBILITY; RESPIRATORY TRACT INFECTION; REVIEW; RISK ASSESSMENT; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; TOTAL QUALITY MANAGEMENT; ADULT; ANTIBIOTIC RESISTANCE; CHILD; INAPPROPRIATE PRESCRIBING; METHODOLOGY; PRIMARY HEALTH CARE; STANDARDS; STATISTICAL ANALYSIS; STATISTICS AND NUMERICAL DATA;

ADULT; ANTI-BACTERIAL AGENTS; CHILD; DATA INTERPRETATION, STATISTICAL; DRUG RESISTANCE, MICROBIAL; HUMANS; INAPPROPRIATE PRESCRIBING; PRIMARY HEALTH CARE; RESEARCH DESIGN; RESPIRATORY TRACT INFECTIONS;

EID: 85020941173     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2017-016253     Document Type: Review

References (55)

1. World Health Organization. Antimicrobial resistance: global report on surveillance, 2014.
2. World Health Organization. Global action plan on antimicrobial resistance, 2015.
3. Chaired by Jim O'neill. Review on antimicrobial resistance: tackling a crisis for the health and wealth of Nations, 2014.
4. Costelloe C, Metcalfe C, Lovering A, et al. Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis. BMJ 2010;340:c2096.
5. Riedel S, Beekmann SE, Heilmann KP, et al. Antimicrobial use in Europe and antimicrobial resistance in Streptococcus pneumoniae. Eur J Clin Microbiol Infect Dis 2007;26:485-90.
6. Goossens H, Ferech M, Vander Stichele R, et al. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 2005;365:579-87.
7. Lee GC, Reveles KR, Attridge RT, et al. Outpatient antibiotic prescribing in the United States: 2000 to 2010. BMC Med 2014;12:96.
8. World Health Organisation. Promoting rational use of medicines: core components. Geneva, Switzerland: World Health Organization, 2002.
9. Gulliford MC, Dregan A, Moore MV, et al. Continued high rates of antibiotic prescribing to adults with respiratory tract infection: survey of 568 UK general practices. BMJ Open 2014;4:e006245.
10. Metlay JP, Stafford RS, Singer DE. National trends in the use of antibiotics by primary care physicians for adult patients with cough. Arch Intern Med 1998;158:1813-8.
11. Little P, Stuart B, Moore M, et al. Amoxicillin for acute lowerrespiratory-tract infection in primary care when pneumonia is not suspected: a 12-country, randomised, placebo-controlled trial. Lancet Infect Dis 2013;13:123-9.
12. Mainous AG, Cheng AY, Garr RC, et al. Nonprescribed antimicrobial drugs in Latino community, South Carolina. Emerg Infect Dis 2005;11:883-8.
13. Richman PB, Garra G, Eskin B, et al. Oral antibiotic use without consulting a physician: a survey of ED patients. Am J Emerg Med 2001;19:57-60.
14. Vanden Eng J, Marcus R, Hadler JL, et al. Consumer attitudes and use of antibiotics. Emerg Infect Dis 2003;9:1128-35.
15. Grigoryan L, Haaijer-Ruskamp FM, Burgerhof JG, et al. Selfmedication with antimicrobial drugs in Europe. Emerg Infect Dis 2006;12:452-9.
16. Altiner A, Brockmann S, Sielk M, et al. Reducing antibiotic prescriptions for acute cough by motivating GPs to change their attitudes to communication and empowering patients: a cluster-randomized intervention study. J Antimicrob Chemother 2007;60:638-44.
17. Wood F, Phillips C, Brookes-Howell L, et al. Primary care clinicians' perceptions of antibiotic resistance: a multi-country qualitative interview study. J Antimicrob Chemother 2013;68:237-43.
18. Arroll B, Goodyear-Smith F, Thomas DR, et al. Delayed antibiotic prescriptions: what are the experiences and attitudes of physicians and patients? J Fam Pract 2002;51:954-9.
19. Little P, Gould C, Williamson I, et al. Reattendance and complications in a randomised trial of prescribing strategies for sore throat: the medicalising effect of prescribing antibiotics. BMJ 1997;315:350-2.
20. Belongia EA, Sullivan BJ, Chyou PH, et al. A community intervention trial to promote judicious antibiotic use and reduce penicillinresistant Streptococcus pneumoniae carriage in children. Pediatrics 2001;108:575-83.
21. Finkelstein JA, Huang SS, Kleinman K, et al. Impact of a 16-community trial to promote judicious antibiotic use in Massachusetts. Pediatrics 2008;121:e15-e23.
22. Seppälä H, Klaukka T, Vuopio-Varkila J, et al. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A Streptococci in Finland. N Engl J Med Overseas Ed 1997;337:441-6.
23. Goossens H, Coenen S, Costers M, et al. Achievements of the Belgian Antibiotic Policy Coordination Committee (BAPCOC). Euro Surveill 2008;13(46().
24. Butler CC, Rollnick S, Pill R, et al. Understanding the culture of prescribing: qualitative study of general practitioners' and patients' perceptions of antibiotics for sore throats. BMJ 1998;317:637-42.
25. Arnold SR, Straus SE. Interventions to improve antibiotic prescribing practices in ambulatory care. Cochrane Database Syst Rev 2005;4:CD003539.
26. MacDougall C, Polk RE. Antimicrobial stewardship programs in health care systems. Clin Microbiol Rev 2005;18:638-56.
27. McDonagh M, Peterson K, Winthrop K, et al. Agency for Healthcare Research and Quality, U. S. Department of Health and Human Services. Improving antibiotic prescribing for uncomplicated acute respiratory tract infections. Rockville MD, 2016.
28. Ranji SR, Steinman MA, Shojania KG, et al. Interventions to reduce unnecessary antibiotic prescribing: a systematic review and quantitative analysis. Med Care 2008;46:847-62.
29. Leung E, Weil DE, Raviglione M, et al. The WHO policy package to combat antimicrobial resistance. Bull World Health Organ 2011;89:390-2.
30. European Union of General Practitioners/Family Physicians (UEMO). EU announces Roadmap on one Health Action Plan on AMR. Bucharest, 2016.
31. Goossens H, Guillemot D, Ferech M, et al. National campaigns to improve antibiotic use. Eur J Clin Pharmacol 2006;62:373-9.
32. Earnshaw S, Monnet DL, Duncan B, et al. European antibiotic awareness day, 2008-the first Europe-wide public information campaign on prudent antibiotic use: methods and survey of activities in participating countries. Euro Surveill 2009;14:19280.
33. Wutzke SE, Artist MA, Kehoe LA, et al. Evaluation of a national programme to reduce inappropriate use of antibiotics for upper respiratory tract infections: effects on consumer awareness, beliefs, attitudes and behaviour in Australia. Health Promot Int 2007;22:53-64.
34. Gonzales R, Corbett KK, Wong S, et al. "Get smart Colorado": impact of a mass media campaign to improve community antibiotic use. Med Care 2008;46:597-605.
35. Shamseer L, Moher D, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ 2015;349:g7647.
36. Harris AM, Hicks LA, Qaseem A, et al. Appropriate antibiotic use for acute respiratory tract infection in adults: advice for High value care from the American College of physicians and the centers for Disease control and prevention. Ann Intern Med 2016;164:425-34.
37. World Health Organization. WHO Model Prescribing Information: drugs used in bacterial infections. Illustrated ed: World Health Organization, 2001.
38. Woodhead M, Blasi F, Ewig S, et al. Guidelines for the management of adult lower respiratory tract infections-full version. Clin Microbiol Infect 2011;17 Suppl 6:E1-E59.
39. Greene G, Hood K, Little P, et al. Towards clinical definitions of lower respiratory tract infection (LRTI) for research and primary care practice in Europe: an international consensus study. Prim Care Respir J 2011;20:299-306.
40. Levinson W, Kallewaard M, Bhatia RS, et al. 'Choosing Wisely': a growing international campaign. BMJ Qual Saf 2015;24:167-74.
41. Selby K, Gaspoz JM, Rodondi N, et al. Creating a list of low-value health care activities in Swiss primary care. JAMA Intern Med 2015;175:640-2.
42. Quick JD, Laing RO, Ross-Degnan DG. Intervention research to promote clinically effective and economically efficient use of pharmaceuticals: the International Network for Rational Use of Drugs. J Clin Epidemiol 1991;44(Suppl 2):57-65.
43. Adriaenssens N, Coenen S, Tonkin-Crine S, et al. European surveillance of antimicrobial consumption (ESAC): disease-specific quality indicators for outpatient antibiotic prescribing. BMJ Qual Saf 2011;20:764-72.
44. Coenen S, Gielen B, Blommaert A, et al. Appropriate international measures for outpatient antibiotic prescribing and consumption: recommendations from a national data comparison of different measures. J Antimicrob Chemother 2014;69:529-34.
45. Collineau L, Belloc C, Stärk KD, et al. Guidance on the selection of appropriate indicators for quantification of antimicrobial usage in humans and animals. Zoonoses Public Health 2017;64:165-84.
46. Centre for Research in Evidence Based Practice (CREBP), Faculty of Health Sciences and Medicine Bond University. Systematic reviews practical manual. 2014.
47. HigginsJ. P. T, GreenS. E. The Cochrane Collaboration. Cochrane Handbook for Systematic Reviews of Interventions. Version 5. 1. 0 [updated March 2011]. 2011.
48. Jüni P, Witschi A, Bloch R, et al. The hazards of scoring the quality of clinical trials for meta-analysis. JAMA 1999;282:1054-60.
49. Effective Practice and Organisation of Care (EPOC). Suggested risk of bias criteria for EPOC reviews. Norwegian knowledge Centre for the Health Services. Oslo: EPOC Resources for review authors, 2015. http:// epoc. cochrane. org/ epoc-specific-resources-review-authors .
50. Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in metaanalyses. Eur J Epidemiol 2010;25:603-5.
51. Sterne JA, Hernán MA, Reeves BC, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ 2016;355:i4919.
52. The Nordic Cochrane Centre, The Cochrane Collaboration. Version 5. 2. 4. Copenhagen: Review Manager (RevMan). 2012.
53. Higgins JP, Thompson SG. Quantifying heterogeneity in a metaanalysis. Stat Med 2002;21:1539-58.
54. Sterne JA, Sutton AJ, Ioannidis JP, et al. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ 2011;343:d4002.
55. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med 2009;6:e1000100.